微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.82% | -31.67% | -43.06% | 89/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 1.44% | -65.3% | 596.55% | 94/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | -0.29% | -105.14% | -114.01% | 115/159 | 4.18% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 2.07% | -40% | 72.5% | 81/159 | 2.63% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.2% | -66.94% | -71.08% | 86/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 4.15% | 56.02% | -26.42% | 70/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 5.64% | 28.77% | 63.48% | 60/159 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 3.45% | 31.68% | -4.96% | 63/159 | 1.47% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 3.63% | 188.1% | 36.47% | 22/159 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 2.66% | -39.55% | -39.27% | 91/159 | 0.74% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 4.38% | -47.86% | 67.18% | 70/159 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 2.62% | -9.97% | 107.94% | 74/159 | 2.22% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.26% | -33.33% | -71.36% | 82/159 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 4.4% | 64.18% | -47.62% | 83/159 | 0.87% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 8.4% | 37.48% | 188.66% | 51/159 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 2.91% | 67.24% | 53.97% | 82/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.89% | 48.82% | -29.48% | 71/159 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 2.68% | -69.55% | -56.14% | 99/159 | 3.71% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 6.11% | -42.95% | 251.15% | 66/159 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 1.74% | -74.78% | 37.01% | 94/159 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 1.27% | -70.87% | -85.57% | 63/159 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 8.8% | -29.88% | -17.83% | 65/159 | 2.71% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 10.71% | -11.71% | 55.22% | 31/159 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 6.9% | -8.49% | 58.26% | 30/159 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 4.36% | 4.31% | -65.26% | 16/159 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 12.55% | 49.58% | 3.46% | 39/159 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 12.13% | 25.96% | 60.88% | 15/159 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 7.54% | 57.08% | 80.38% | 19/159 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 4.18% | 30.22% | -50.18% | 14/159 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 8.39% | -24.55% | -12.88% | 61/159 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 9.63% | 0.52% | 100.63% | 33/159 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 4.8% | -26.15% | 49.53% | 47/159 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 3.21% | -21.52% | -71.13% | 23/159 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 11.12% | -28.67% | 16.08% | 49/159 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 9.58% | -37.63% | 47.38% | 25/159 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 6.5% | -26.8% | 58.92% | 30/159 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 4.09% | -25.91% | -73.77% | 18/159 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 15.59% | -30.31% | 1.5% | 34/159 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 15.36% | -18.69% | 72.97% | 11/159 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 8.88% | -27.45% | 60.87% | 16/159 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 5.52% | -13.34% | -75.32% | 9/159 | 2.41% | 华东医药 | 26.63% | 行业排名> |